Dermorphin
Opioid heptapeptide (amphibian derived)
A naturally occurring D-amino acid peptide with extremely high mu opioid receptor affinity in study models.
How it works
Its D-alanine residue resists peptidase breakdown and gives selective, very high affinity binding at the mu opioid receptor.
What research has shown
Animal studies report analgesic potency far above morphine on a weight basis. It is a controlled research substance in most jurisdictions.
Reported ranges in the literature
Low end
Animal model concentrations only
Optimal
No legitimate human research range
High end
Not characterized
Frequency reported in the literature: Not established. Note: Controlled opioid research compound. Listed for reference completeness only.
Protocol duration and pairing
Typical study duration
Preclinical exposures are short, typically under 4 weeks.
Best paired with
Studied on its own. No established pairing appears in the literature.
Opioid receptor research compound with no stacking literature.
Research use only
All content on this page is general reference information for laboratory research contexts. It is not medical advice, is not intended to direct human use, and does not replace guidance from a licensed healthcare professional. Not for human consumption. Must be 18+.